LYMPHOMAP Inc. – Trademark Portfolio
Entity Type: 03
LYMPHOMAP Inc. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 3 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 5 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include LBIL and LYMPHOMAP. The owner is based in Long Island City, NY.
Long Island City, NY 11101
Showing of trademarks Trademarks
Trademark Classifications
LYMPHOMAP Inc.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does LYMPHOMAP Inc. have?
LYMPHOMAP Inc. has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.
What trademark classes does LYMPHOMAP Inc. file in?
LYMPHOMAP Inc. files trademarks across 5 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 44 (Medical Services), Class 38 (Telecommunications), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 35 covers advertising; business management; business administration; office functions.
What are LYMPHOMAP Inc.'s most well-known trademarks?
LYMPHOMAP Inc.'s registered trademark portfolio includes well-known marks such as LBIL and LYMPHOMAP. These are among 2 currently registered trademarks in the portfolio.
What is LYMPHOMAP Inc.'s trademark registration success rate?
LYMPHOMAP Inc. has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.